Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note.
Malhotra
Manjusha
M
Department of Pharmaceutics, Delhi Institute of Pharmaceutical Sciences and Research, Formerly College of Pharmacy, University of Delhi, Pushp Vihar, Sector III, New Delhi-110017, India.
Majumdar
Dipak K
DK
D000287:Administration, Topical; D000818:Animals; D015232:Dinoprostone; D004339:Drug Compounding / Q000379:methods*; D005079:Excipients / Q000737:chemistry*; D005260:Female; D020910:Ketorolac / Q000008:administration & dosage* / Q000737:chemistry*; D008297:Male; D009821:Oils / Q000737:chemistry; D009824:Ointments / Q000737:chemistry; D010000:Osteitis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy*; D011817:Rabbits; D016896:Treatment Outcome; D014867:Water / Q000737:chemistry
D005079:Excipients; D009821:Oils; D009824:Ointments; D014867:Water; D015232:Dinoprostone; D020910:Ketorolac